GlaxoSmithKline (NYSE:GSK) reported its Q4 earnings results on Wednesday, February 9, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Check out this: Executives Buy Around $64M Of 3 Stocks
Earnings
GlaxoSmithKline beat estimated earnings by 6.15%, reporting an EPS of $0.69 versus an estimate of $0.65.
Revenue was up $1.22 billion from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.2, which was followed by a 4.21% increase in the share price the next day.
Here's a look at GlaxoSmithKline's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | 0.81 | 0.57 | 0.61 | 0.64 |
| EPS Actual | 1.01 | 0.79 | 0.63 | 0.62 |
| Revenue Estimate | 11.88B | 10.54B | 11.06B | 11.60B |
| Revenue Actual | 12.44B | 11.33B | 10.24B | 11.62B |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
